Trial intelligence / Profile preview

Nalbuphine vs Hydromorphone for Analgesia in ICU Patients

NCT06785571Phase 3Recruiting

Start
Aug 2023
Primary completion
Oct 2025
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of nalbuphine in pain. Started Aug 2023; status: recruiting.

02

Drugs

nalbuphine
03

Conditions

pain

Beyond the preview

Go deeper on NCT06785571.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06785571.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call